Scientists discover two unique subtypes of a prominent mutation in patients with AML
Scientists discover two unique subtypes of a prominent mutation in patients with AML Using advanced RNA sequencing, scientists have identified two unique subtypes of a prominent mutation present in many patients with Acute Myeloid Leukemia (AML) – called NPM1 – that could help predict survival and improve treatment response for patients whose leukemic cells bear the mutation. In research published Feb. 16, in Nature Communications, a team led by Princess Margaret Cancer Centre Senior Sci...
Source: news-medical.net